Vice President, Global Medical Affairs, Neuroscience

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit. Job Function: Medical Affairs Group Job Sub Function: Medical Affairs Job Category: People Leader All Job Posting Locations: Raritan, New Jersey, United States of America Job Description: We are searching for the best talent for a Vice President, Global Medical Affairs, Neuroscience located in Raritan, NJ. About Neuroscience Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Neuroscience team is changing the trajectory of mental health and other brain and nervous-system disorders. You can influence where medicine is going by helping to restore health and hope to the millions of people living with mood, psychiatric and neurological conditions. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine The Vice President, Global Medical Affairs, Neuroscience is accountable for delivering integrated Global Medical Affairs strategies and operational plans that reflect the unique requirements of key regional, patient, payor (public and private), regulatory, and physician stakeholders by leading a team responsible for the development of strategic and tactical Medical Affairs plans for the TA portfolio. The Global Medical Affairs team is also accountable for the global data dissemination planning and execution, opinion leader and external expert engagement, medical education across the portfolio as well as global patient advocacy and engagement strategy and execution for the TA. They will drive robust evidence generation and data dissemination plans that reflect the clinical differentiation of our innovative medicines in collaboration with policy and access colleagues. The Vice President, Global Medical Affairs Neuroscience partners closely with Regional Medical Affairs Colleagues to develop integrated global medical affairs perspectives, strategies and plans as well as to maintain open, two-way communication to ensure regional medical affairs teams are up to date on all plans, progress milestones and decisions. They will ensure comprehensive life-cycle management strategies and plans are developed and coordinated globally by the Global Medical Affairs Leader(s) (GMALs) for key assets in the NS disease areas of focus and key adjacencies. The Vice President, Global Medical Affairs Neuroscience will collaborate closely with his/her R&D, Regional MAF, Global Public Health, and BD&L colleagues and have people management responsibility for assigned TA GMAL The VP GMAF is also member of the Labelling Committee (LC) GMAF representatives provide a single Medical Affairs voice into the creation of compound development and life cycle management strategies, plans and trial design from phase IIa through phase IV. GMAF also serves as core representatives of the Safety Management team for marketed and late-stage portfolio compounds and provide support for the development of the Company risk management strategy, plans and Periodic benefit-risk assessment reports. GMA also perform medical impact assessments as required. The Vice President, Global Medical Affairs Neuroscience is responsible to ensure all global activities follow J&J Compliance principles. The VP GMAF NS is responsible for medical oversight of GCSO-Sponsored activities which may include Market Research, Clinical Trials/Studies (Company-Sponsored, Investigator-Initiated, & Collaborative Studies), Medical Reviews of regulatory documents, and reviewing Medically Important Results (MIR), and other Research Related Activities. Other Duties / Tasks Accountable to deliver integrated Global Medical Affairs strategies and operational plans that reflect the unique requirements of key regional, patient, payor (public and private), regulatory, and physician stakeholders. Drive robust data generation and dissemination plans that reflect the clinical differentiation and, in collaboration with policy and access colleagues, pharmacoeconomic value of therapeutic innovations within the NS TA Ensure comprehensive life-cycle management strategies and plans are developed and coordinated globally by the Global Medical Affairs Leader(s) (GMALs) for key assets in the NS disease areas of focus and key adjacencies. Be responsible for driving and executing the medical strategies leading innovative approaches to population health, data-mining, predictive analytics, disease interception, and outcomes-based partnerships / pilots designed to offer integrated customer solutions in disease areas of focus. This position will be responsible for the development and execution of globally and functionally integrated, consistent, and compliant approaches towards patient access, external scientific relations, medical education, and publication planning for the NS portfolio. Be a primary contact for external interactions with key opinion leaders, academic institutions, medical organizations, world health, partners, and consultants. This role will serve a critical leadership function on the GCSO NS Leadership Team, GMAF Leadership Team and the combined R&D / GCSO NS Senior Leadership Teams with accountability for TA strategic oversight with a particular focus on: Portfolio prioritization and investment Disease Area strategies and budgets Cross-Disease Area resource allocate Licensing, merger and acquisition activities GMAF also serves as core representatives of the Safety Management team for marketed and late stage portfolio compounds and provide support for the development of the Company risk management strategy, plans and Periodic benefit-risk assessment reports. GMAF perform Medical Im